PGR and breast cancer: The fact that decision-making regarding adequate treatment of patients with BC is based on hormonal receptors, and limited research has been done recently at the national level, it is our hope that advanced studies involving adequately powered samples and other molecular markers, including ER, PR and Her-2, can further be conducted in order to individualize therapeutic schemes without delay.